
Concord Biotech Ltd Opens Strong with Significant Gap Up on 3 Feb 2026
2026-02-03 11:08:02Concord Biotech Ltd commenced trading with a significant gap up of 5.92% on 3 February 2026, signalling a robust start amid positive market sentiment in the Pharmaceuticals & Biotechnology sector. This upward opening follows a three-day decline, marking a notable reversal in the stock’s recent trend.
Read full news article
Concord Biotech Ltd Falls to 52-Week Low of Rs.1121
2026-02-02 10:01:00Concord Biotech Ltd’s shares touched a fresh 52-week low of Rs.1121 today, marking a significant decline amid a broader market recovery. The stock has underperformed its sector and benchmark indices, reflecting ongoing pressures on its financial performance and valuation metrics.
Read full news article
Concord Biotech Ltd Falls to 52-Week Low Amidst Continued Downtrend
2026-02-01 12:45:33Concord Biotech Ltd’s stock price declined to a fresh 52-week low of Rs.1157 today, marking a significant milestone in its ongoing downward trajectory. The pharmaceutical and biotechnology company’s shares have been under pressure, reflecting a combination of subdued financial performance and broader market dynamics.
Read full news article
Concord Biotech Ltd is Rated Strong Sell
2026-01-31 10:10:48Concord Biotech Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 23 October 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 31 January 2026, providing investors with the latest insights into its performance and outlook.
Read full news article
Concord Biotech Ltd Falls to 52-Week Low of Rs 1159 Amidst Continued Downtrend
2026-01-30 11:27:35Concord Biotech Ltd’s shares declined to a fresh 52-week low of Rs.1159 on 30 Jan 2026, marking a significant drop amid sustained underperformance relative to its sector and benchmark indices. The stock’s latest intraday low represents a near 53% fall from its 52-week high of Rs.2451.65, reflecting ongoing pressures on the company’s financial metrics and market sentiment.
Read full news article
Concord Biotech Ltd Falls to 52-Week Low of Rs.1175.65
2026-01-28 10:05:12Concord Biotech Ltd’s stock declined sharply to a fresh 52-week low of Rs.1175.65 today, marking a significant downturn as the pharmaceutical and biotechnology company continues to face headwinds. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its financial performance and valuation metrics.
Read full news article
Concord Biotech Ltd Falls to 52-Week Low of Rs 1175.65
2026-01-28 10:05:09Concord Biotech Ltd’s stock declined sharply to a fresh 52-week low of Rs.1175.65 on 28 Jan 2026, marking a significant downturn amid a sustained period of underperformance relative to its sector and broader market indices.
Read full news article
Concord Biotech Ltd Falls to 52-Week Low of Rs.1211.1 Amidst Continued Downtrend
2026-01-27 10:50:59Concord Biotech Ltd’s shares declined to a fresh 52-week low of Rs.1211.1 on 27 Jan 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical and biotechnology company’s stock has underperformed both its sector and the broader market, reflecting a series of financial and valuation pressures.
Read full news article
Concord Biotech Ltd Falls to 52-Week Low of Rs.1225.3 Amidst Prolonged Downtrend
2026-01-22 11:10:38Concord Biotech Ltd’s stock touched a fresh 52-week low of Rs.1225.3 today, marking a significant decline amid a sustained downward trajectory over the past year. This new low reflects ongoing pressures on the company’s financial performance and valuation metrics within the Pharmaceuticals & Biotechnology sector.
Read full news articleCorporate Actions
No Upcoming Board Meetings
Concord Biotech Ltd has declared 1070% dividend, ex-date: 03 Sep 25
No Splits history available
No Bonus history available
No Rights history available






